Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Beneficial effects of the dual L- and T-type ca(2+) channel blocker efonidipine on cardiomyopathic hamsters.

Beneficial effects of the dual L- and T-type ca(2+) channel blocker efonidipine on cardiomyopathic hamsters. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Beneficial effects of the dual L- and T-type ca(2+) channel blocker efonidipine on cardiomyopathic hamsters. Abstract Text:

    shinsuke suzukiShinsuke Suzuki,tomoko ohkusaTomoko Ohkusa,katsushige onoKatsushige Ono,takashi satoTakashi Sato,masa-aki yoshidaMasa-Aki Yoshida,masafumi yanoMasafumi Yano,satoshi takebayashiSatoshi Takebayashi,masunori matsuzakiMasunori Matsuzaki,shinsuke suzukiShinsuke Suzuki,tomoko ohkusaTomoko Ohkusa,katsushige onoKatsushige Ono,takashi satoTakashi Sato,masa-aki yoshidaMasa-aki Yoshida,masafumi yanoMasafumi Yano,satoshi takebayashiSatoshi Takebayashi,masunori matsuzakiMasunori Matsuzaki,shinsuke suzukiShinsuke Suzuki,tomoko ohkusaTomoko Ohkusa,katsushige onoKatsushige Ono,takashi satoTakashi Sato,masa-aki yoshidaMasa-aki Yoshida,masafumi yanoMasafumi Yano,satoshi takebayashiSatoshi Takebayashi,masunori matsuzakiMasunori Matsuzaki,

    Background The T-type Ca(2+) channel (TCC) is activated, and abnormalities of the TCC may be related to the pathogenesis of Ca(2+) overload, in cardiomyopathic hamster hearts. The aims of the present study were to investigate the alteration in expression of the TCC and to examine the effects of a dual L-and T-type Ca(2+) channel blocker, efonidipine (EFO), on cardiac function and TCC during development of heart failure in UM-X7.1 cardiomyopathic hamsters. Methods and Results UM-X7.1 and golden hamsters were examined, and EFO was administered at the age of 20 weeks for 4 weeks. Cardiac function was examined, the expression of TCCalpha1G was measured, and ventricular myocytes were subjected to a patch-clamp study. At 24 weeks, vehicle-treated UM-X7.1 hamsters exhibited significant increases in left ventricular (LV) size, with marked decreases in ejection fraction (LVEF) compared with golden hamsters. In the UM-X7.1 group, the expression of TCCalpha1G increased during development of heart failure compared with the golden hamster group. In the UM-X7.1 group, EFO treatment significantly attenuated the decrease of LVEF without affecting blood pressure compared with the vehicle group. EFO treatment decreased heart rate (by~10%) in both groups. In the golden hamster group, EFO treatment did not affect LV function. The TCC current in ventricular myocytes was significantly increased in UM-X7.1, and was inhibited by EFO in a dose-dependent manner. Conclusions In cardiomyopathic hamster hearts, abnormalities in the TCC may be at least in part related to the pathogenesis of abnormal Ca(2+) homeostasis, and TCC-blocker treatment may decrease the TCC current, resulting in an improvement of cardiac function. TCC blocker therapy might be a new strategy for certain types of heart failure. (Circ J 2007; 71: 1970 - 1976).

    Beneficial effects of the dual L- and T-type ca(2+) channel blocker efonidipine on cardiomyopathic hamsters. Publishing Authors By Initials

    s suzukiS Suzuki,t ohkusaT Ohkusa,k onoK Ono,t satoT Sato,ma yoshidaMA Yoshida,m yanoM Yano,s takebayashiS Takebayashi,m matsuzakiM Matsuzaki,s suzukiS Suzuki,t ohkusaT Ohkusa,k onoK Ono,t satoT Sato,ma yoshidaMA Yoshida,m yanoM Yano,s takebayashiS Takebayashi,m matsuzakiM Matsuzaki,s suzukiS Suzuki,t ohkusaT Ohkusa,k onoK Ono,t satoT Sato,ma yoshidaMA Yoshida,m yanoM Yano,s takebayashiS Takebayashi,m matsuzakiM Matsuzaki,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Beneficial effects of the dual L- and T-type ca(2+) channel blocker efonidipine on cardiomyopathic hamsters. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Circulation journal : official journal of the Japa

    VOLUME: 71

    Page Numbers: 1970-6

    Journal Abbreviation: Circ. J.

    ISSN: 1346-9843

    DAY: 26

    MONTH: Dec

    YEAR: 2007

    Beneficial effects of the dual L- and T-type ca(2+) channel blocker efonidipine on cardiomyopathic hamsters. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101137683

    Beneficial effects of the dual L- and T-type ca(2+) channel blocker efonidipine on cardiomyopathic hamsters. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Beneficial effects of the dual L- and T-type ca(2+) channel blocker efonidipine on cardiomyopathic hamsters. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Beneficial effects of the dual L- and T-type ca(2+) channel blocker efonidipine on cardiomyopathic hamsters.

    AFFILIATION: Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine.

    Country: Japan

    Japan Research PublicationJapan Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Circ J

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Beneficial effects of the dual L- and T-type ca2+ channel blocker efonidipine on cardiomyopathic hamsters Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News